PMC6589247_01
Effects of therapy on RCC ((a) pretreatment CT (10/27/2017), (b) posttreatment CT (1/17/2019)) and bony lesions ((a) pretreatment NM bone scan (10/27/2019), (b) posttreatment NM bone scan (1/16/2019)).
CRIONM2019-6246209.001.jpg
PMC6589247_01_CRIONM2019-6246209.001.jpg
fig1
Staging computerized tomography (CT) showed bilateral pulmonary nodules (all < 3 mm), a 5 cm lower pole left kidney mass, renal vein thrombus, and innumerable sclerotic bone lesions (Figure 1). The patient currently remains on this combination of nivolumab and nab-paclitaxel with her last CT (Figure 1) showing stable disease (current duration of therapy: 10 months).